Back to RXRX
ARK Investment Management LLC → RXRX
ARK Investment Management LLC RXRX Position History
Recursion Pharmaceuticals, Inc.
Quarters held
13
Latest value
$151.7M
Q2 2026
Peak value
$245.1M
First seen
Q2 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2023 | $35.4M |
| Q3 2023 | $52.6M |
| Q4 2023 | $203.7M |
| Q1 2024 | $245.1M |
| Q2 2024 | $211.1M |
| Q3 2024 | $215.9M |
| Q4 2024 | $218.7M |
| Q1 2025 | $184.2M |
| Q2 2025 | $166.9M |
| Q3 2025 | $163.7M |
| Q4 2025 | $152.6M |
| Q1 2026 | $123.5M |
| Q2 2026 | $151.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $151.7M | 41.34M | — | — |
| Q1 2026 | $123.5M | 40.21M | — | — |
| Q4 2025 | $152.6M | 37.32M | — | — |
| Q3 2025 | $163.7M | 33.55M | — | — |
| Q2 2025 | $166.9M | 32.99M | — | — |
| Q1 2025 | $184.2M | 34.82M | — | — |
| Q4 2024 | $218.7M | 32.35M | — | — |
| Q3 2024 | $215.9M | 32.77M | — | — |
| Q2 2024 | $211.1M | 28.14M | — | — |
| Q1 2024 | $245.1M | 24.59M | — | — |
| Q4 2023 | $203.7M | 20.65M | — | — |
| Q3 2023 | $52.6M | 6.88M | — | — |
| Q2 2023 | $35.4M | 4.74M | — | — |
Other funds holding RXRX
$178.6M
$178.3M
$176.5M
$167.5M
$127.4M
$127.4M
$119.8M